Research Tracker›Biomarker Atlas›Lyme Disease›IgG immunoblot (≥5 of 10 bands)

IgG immunoblot (≥5 of 10 bands) in Lyme Disease

In Lyme Disease (Lyme borreliosis, Borrelia burgdorferi infection), published studies report higher levels of IgG immunoblot (≥5 of 10 bands), also described as Tier 2 confirmatory, than in Uninfected. The cited literature links this alteration to disseminated / late Lyme. The finding is drawn from CDC 2024; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedSerologic

Summary

Direction in Lyme Disease↑ Elevated — higher than in the comparison group
CategorySerologic
Also described asTier 2 confirmatory
Compared againstUninfected
Associated symptomsDisseminated / late Lyme
Test typeBlood test (serum / plasma / whole blood)
SourceCDC 2024 — doi:10.1016/j.idc.2021.05.001
Condition atlasLyme Disease Biomarker Atlas

Trials, interventions and tests

Commercial test availability

Lyme IgG Immunoblot (Western Blot) — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Serologic markers in Lyme Disease

Full list: Lyme Disease Biomarker Atlas.

Frequently asked questions

Is IgG immunoblot (≥5 of 10 bands) high or low in Lyme Disease?

Elevated. Studies summarised in the OSMF atlas report higher IgG immunoblot (≥5 of 10 bands) in Lyme Disease than in Uninfected. Source: CDC 2024.

What symptoms is IgG immunoblot (≥5 of 10 bands) associated with in Lyme Disease?

The cited literature associates this marker with Disseminated / late Lyme. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures IgG immunoblot (≥5 of 10 bands)?

It is measured as a blood test (serum / plasma / whole blood). Commercial laboratories such as LabCorp, Quest Diagnostics list an orderable assay.

Is one abnormal IgG immunoblot (≥5 of 10 bands) result diagnostic of Lyme Disease?

No. No single biomarker is diagnostic of Lyme Disease. IgG immunoblot (≥5 of 10 bands) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). IgG immunoblot (≥5 of 10 bands) in Lyme Disease: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/lyme/igg-immunoblot-ge5-of-10-bands.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from lyme.json · Browse: Lyme Disease atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.